How should adenosine be administered for supraventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Administer Adenosine for SVT

Administer adenosine as a rapid IV bolus through a proximal (large-bore) peripheral vein, starting with 6 mg, followed immediately by a 20 mL saline flush, with continuous ECG monitoring throughout the administration. 1

Administration Technique

Route and Preparation

  • Use a proximal peripheral IV (antecubital or higher) for optimal delivery
  • Have the adenosine dose drawn up and ready
  • Prepare a 20 mL saline flush in a separate syringe
  • Ensure continuous ECG recording is running before, during, and after administration 1

Injection Protocol

  • Push the adenosine as a rapid bolus (over 1-2 seconds, not a slow push)
  • Immediately follow with a rapid 20 mL saline flush to ensure the drug reaches central circulation before it degrades
  • The extremely short half-life (seconds) means any delay in flushing will result in failure 1

Dosing Strategy

Standard peripheral dosing:

  • First dose: 6 mg rapid IV bolus
  • If no conversion after 1-2 minutes: 12 mg rapid IV bolus
  • If still no conversion: 12 mg again (third dose) 2

This sequential approach achieves cumulative success rates of 57.4% after 6 mg and 93.4% after the second 12 mg dose 2.

Important dosing considerations:

  • Recent evidence suggests the standard 6 mg initial dose may be suboptimal in heavier patients (>75-80 kg), with weight-adjusted dosing of 0.09-0.10 mg/kg potentially more effective 3, 4
  • Some recent data support starting with 12 mg as the initial dose, showing 83% first-dose conversion versus 52% with 6 mg 4
  • Central line dosing requires lower doses: Start with only 3 mg if administering through a central venous catheter, as 77% of patients convert with this dose centrally versus only 37% peripherally 5

Critical Safety Measures

Before Administration

  • Have resuscitation equipment immediately available, including defibrillator and crash cart 1, 6
  • Ensure the patient does NOT have:
    • Pre-excited atrial fibrillation (wide, irregular QRS) - adenosine is contraindicated
    • Severe asthma or active bronchospasm - adenosine is contraindicated 6
    • High-grade AV block without a pacemaker - adenosine is contraindicated 6

During Administration

  • Warn the patient they will experience unpleasant but brief (<60 seconds) sensations: chest pressure/pain, dyspnea, flushing, sense of impending doom 1, 2
  • Watch the monitor continuously - conversion typically occurs within 30 seconds of injection 2
  • Document the rhythm strip showing the moment of conversion (or failure)

After Administration

  • Watch for immediate recurrence - SVT can reinitiate within seconds to minutes in some patients 1
  • Monitor for transient arrhythmias post-conversion (common and usually benign): premature atrial/ventricular beats, brief pauses 1
  • Rare but serious: adenosine can precipitate atrial fibrillation, which in patients with WPW can conduct rapidly and degenerate to ventricular fibrillation 1, 6

Clinical Context and Alternatives

When Adenosine Fails or is Contraindicated

  • Hemodynamically unstable patients: Proceed directly to synchronized cardioversion if adenosine fails or is not feasible 1
  • Stable patients with failed adenosine: Consider IV calcium channel blockers (diltiazem, verapamil) or beta-blockers, though these have been downgraded in recent guidelines 7
  • Pre-excited AF (irregular wide-complex): Use procainamide or ibutilide, NOT adenosine 1

Diagnostic Value

Even when adenosine doesn't terminate the arrhythmia, it provides diagnostic information by:

  • Unmasking atrial flutter or atrial tachycardia through transient AV block
  • Distinguishing true drug failure from successful termination with immediate reinitiation 1

Common Pitfalls to Avoid

  1. Slow push or inadequate flush - The most common reason for adenosine failure is not pushing fast enough or failing to flush immediately and rapidly
  2. Using a distal IV site (hand, wrist) - Drug degrades before reaching the heart
  3. Not having the ECG recording - You lose critical diagnostic information
  4. Giving adenosine for irregular wide-complex tachycardia - This may be pre-excited AF where adenosine is dangerous
  5. Underdosing in obese patients - Consider higher initial doses (12 mg) or weight-based dosing in patients >80 kg 3, 4
  6. Using standard peripheral doses through central lines - This delivers excessive drug to the heart; reduce to 3 mg initially 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.